Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Zohar Krivorot

Recent news which mentions Zohar Krivorot

Cannara Biotech Reports 6% YoY Drop In Q3 Gross Profit, 22% Revenue Increase As It Enhances Sales Force And Infrastructure
Tickers CCC LOVE LOVE LOVFF
Tags Zohar Krivorot LOVFF Benzinga
From Benzinga
Cannara Biotech Q3 FY23 Net Revenue Grows 57% YoY, What About Adjusted EBITDA?
Tickers LOVFF
Tags News Zohar Krivorot premium
From Benzinga
Cannara Biotech Q2 FY23 Revenue Grows 76% YoY To $9.6M, Here Are The Details
Tickers LOVFF
Tags Cannabis Market News Markets
From Benzinga
Cannara Biotech Q4 Revenue Grows 84% YoY To $8.9M
Tickers LOVFF
Tags News Penny Stocks Earnings
From Benzinga
Cannara Biotech Enters Into The British Columbia Cannabis Market And Launches New Products
Tickers LOVFF
Tags Cannabis Market News Markets
From Benzinga
Cannara Biotech Revenue Grows 41% YoY, Here Are The Details
Tickers LOVFF
Tags Cannabis Market News Markets
From Benzinga
Cannara Biotech Revenues Grew 229% To $7.4M In Q2 2022 YoY
Tickers LOVFF
Tags Markets Market News Cannabis
From Benzinga
Cannara Biotech Shares Surge On 983% QoQ Revenue Growth, Positive Adjusted EBITDA
Tickers CGC LOVFF
Tags CGC Benzinga LOVFF
From Benzinga
Cannara Biotech Cannabis Co. Slightly Beats Estimates, Posts $7.2M In Q3 2021 Revenue
Tickers LOVFF TGODF
Tags third quarter earnings TGODF Zohar Krivorot
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback